Advertisement

Topics

Pfizer Boss Ian Read Claims They Won't Buy Bristol-Myers Squibb or Make Any Other Big Deals

20:00 EDT 12 Apr 2018 | BioSpace

There has been speculation for several years whether Pfizer Inc. would consider buying Bristol-Myers Squibb. That appears to have been laid to rest by comments made by Pfizer’s chief executive officer, Ian Read.

Original Article: Pfizer Boss Ian Read Claims They Won't Buy Bristol-Myers Squibb or Make Any Other Big Deals

NEXT ARTICLE

More From BioPortfolio on "Pfizer Boss Ian Read Claims They Won't Buy Bristol-Myers Squibb or Make Any Other Big Deals"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...